Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
13 August 2010
IN THIS ISSUE
Merck probe
Facebook warning
PTE August
Holding and distribution
Merck probed for corrupt foreign practices
Merck has received letters from the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) seeking information about “activities in a number of countries” with reference to the Foreign Corrupt Practices Act. More...
 
Novartis gets warning letter for Facebook widgit
Novartis has been told off by the FDA in a letter about a social media Facebook widgit that appears on the company’s Tasigna website. More...
 
August issue of PTE now available online
This month’s issue of PTE features articles on packaging line efficiency, sterile production with a focus on capping and a special feature that examines the challenges of developing biosimilars. More...
 
FDA summarises GMP for holding and distribution
The FDA has published a summary of GMP for the holding and distribution of drug products, which provides information about human drug recalls, including details about the agency’s authority and manufacturers’ responsibilities. More...
 
Senate introduces new bill on drug manufacturing quality standards
A US Senator has introduced the Drug Safety and Accountability Act of 2010, which is designed to improve regulatory oversight of drug manufacturing facilities and improve related quality standards and monitoring. More...
 
Join our community on LinkedIn
Want to discuss any of this week’s news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
Will Sanofi Bag Genzyme?
Building the right incentives
FDA needs more muscle and money
More blog posts

Latest articles
New technologies for pharmaceutical manufacturing: addressing cost, containment and cGMP requirements
Vacuum conveying in the pharmaceutical industry
The new EMA bioequivalence guideline: key considerations
More latest articles

Upcoming events
DigiPharm Europe 2010 (28 September–1 October | UK)
Biobusiness Network (29–30 September | Switzerland)
Innovation in drug delivery: from preformulation to development through innovative evaluation process (3–6 October | France)
More events

Event Profile
CPHI Worldwide
October 5 - 7 2010
Paris Nord Villepinte Exhibition Centre
Paris, France
30 Word profile

CPhl Worldwide is co-located with three key pharma events, the synergy between the four co-hosted shows- CPhI Worldwide for ingredients; ICSE for Contract Services; P-MEC for Pharma technology, equipment & machinery & BioPh for the biopharma sector.

Read more...



Survey
What is your main concern regarding the outsourcing of various services to emerging countries?
  Safety and quality issues  43%
  Lack of regulation 20%
  Job losses in the West 15%
  The distance 4%
  I have no concerns 18%

This week we would like to know...

Do you agree with the US Federal Trade Commission that pay-to-delay deals are anticompetitive?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom